Core Scientific shares drop almost 5% after technical weakness and dominant seller control

Traders Union
All News
Stocks
Core scientific slides 4.72% today

Highlights

Shares of Core Scientific trade below all major moving averages, indicating ongoing selling pressure across timeframes.
Technical signals including MACD, ADX, RSI, Stochastic RSI, and CCI all indicate strong bearish momentum and persistent downside risk.
Expected five-day price range is $15.13 to $17.19, with a very high probability of a downward move.

Anton Kharitonov, expert at Traders Union, sees Core Scientific's setup as distinctly negative. He notes a firm technical bias as the price remains below all major moving averages and momentum signals point to persistent selling. Absent any supportive news, he cautions that sentiment remains weak and considers the stock's oversold technicals as a warning sign, not a buying opportunity. Critical downside risks dominate, especially with the high chance of further declines below $15.13. "In my view, the sustained lack of positive drivers and entrenched bearish momentum make any near-term recovery unlikely."

Viktoras Karapetjanc, expert at Traders Union, maintains a constructive outlook even amid short-term weakness. He highlights that the longer-term bullish structure of the moving averages remains intact, which could support future recovery. Despite the recent pullback, Karapetjanc sees opportunity for patient investors, especially if the price finds support near $15.13. He encourages monitoring for a breakout above $17.19 as a signal of renewed momentum. "This market offers multiple setups — any stabilization above key supports could provide an attractive entry for forward-looking participants."

Parshwa Turakhiya, analyst, views the current market tone as dominated by negative sentiment and technical weakness. He notes that immediate momentum and intraday price action confirm persistent bearishness, with no sign of a reversal. Traders may watch for a short-term bounce if oversold pressures intensify, but caution is warranted near support at $15.13. "Short-term opportunities may arise, but traders should stay nimble and respect the dominant bearish setup."

Bearish daily momentum confirmed as technical signals align lower

Core Scientific is trading below all its key moving averages, with the current price of $16.16 positioned beneath the 20-day ($17.74), 50-day ($20.15), and 200-day ($19.76) moving averages. This alignment signals ongoing pressure from sellers in the short, medium, and long term, confirming a bearish structure despite the bullish longer-term alignment of the MA-50 versus the MA-200. The nearest resistance is the near-term ceiling at $16.2, while the next support sits at the near-term floor of $15.13. Momentum indicators show persistent bearishness. The Moving Average Convergence Divergence (MACD) signals a strong sell, and the Average Directional Index (ADX) also suggests downward pressure is in control. The Relative Strength Index (RSI), Stochastic RSI, and Commodity Channel Index (CCI) all forecast a sell, indicating no signs of an overbought rebound and continued downside risk. Bull/Bear Power (BBP) is negative, highlighting that sellers dominate, and it is also flagged as oversold. The daily action reflects these signals, as the stock is trading down $0.8 or 4.72%, with a downside gap of around $0.08 (0.47%). Price action sits near the session’s low, and intraday volatility stands at 4.32%. Momentum and price action both reinforce a clear intraday bearish tone with persistent pressure after the open.

Earlier, analysts noted that Core Scientific was facing ongoing technical weakness and heightened volatility, with downside risks prevailing. The latest analysis reinforces this bearish outlook with even stronger selling momentum, highlighting $15.13 as the critical support level to monitor in the coming sessions.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.